HCFA Needs to Do More to Prevent Medicare/Medicaid Fraud and Abuse

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 7
Volume 4
Issue 7

WASHINGTON--Medicare and Medicaid are hard pressed to stay ahead of profiteers bent on cheating the system administered by the Health Care Financing Administration (HCFA).

WASHINGTON--Medicare and Medicaid are hard pressed to stay aheadof profiteers bent on cheating the system administered by theHealth Care Financing Administration (HCFA).

Sarah F. Jaggar, director of health financing and policy issuesfor HCFA, testified before the House Subcommittee on Human Resourcesand Intergovernmental Relations that HCFA's fraud and abuse preventionprograms are weak.

She said that Medicare and Medicaid offer strong incentives forproviders to overprovide services, that HCFA has few controlsto detect questionable billing practices and too few limits onthe types of providers allowed to bill the federal agency, andthat there is little chance that profiteers will be prosecutedor will have to repay fraudulently obtained money.

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content